Wilson Wai-Shun Cheung's Net Worth
$3.6 Million
Who is Wilson Wai-Shun Cheung?
Wilson Wai-Shun Cheung has an estimated net worth of $3.6 Million. This is based on reported shares across multiple companies, which include AXT INC, and SCICLONE PHARMACEUTICALS INC.
SEC CIK
Wilson Wai-Shun Cheung's CIK is 0001291656
Past Insider Trading and Trends
2016 was Wilson Wai-Shun Cheung's most active year for acquiring shares with 11 total transactions. Wilson Wai-Shun Cheung's most active month to acquire stocks was the month of February. 2017 was Wilson Wai-Shun Cheung's most active year for disposing of shares, totalling 23 transactions. Wilson Wai-Shun Cheung's most active month to dispose stocks was the month of September. 2016 saw Wilson Wai-Shun Cheung paying a total of $745,371.41 for 302,333 shares, this is the most they've acquired in one year. In 2017 Wilson Wai-Shun Cheung cashed out on 612,167 shares for a total of $2,933,398.41, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AXT INC (AXTI) Snapshot price: $2.31
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1K |
$1.26 | $1,259.90 | 1K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
$3.68 | -$47,642.00 |
0
|
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$3.62 | -$9,384.00 |
0
|
Scheduled
|
Apr 28
| ||
Form 4
|
—
|
0
|
$3.62 | -$27,600.00 |
0
|
Scheduled
|
Apr 7
| ||
Form 4
|
—
|
0
|
$3.63 | -$24,910.20 |
0
|
Scheduled
|
Mar 27
| ||
Form 4
|
—
|
0
|
$3.62 | -$2,760.00 |
0
|
Scheduled
|
Mar 24
| ||
Form 4
|
—
|
0
|
$3.64 | -$27,882.00 |
0
|
Scheduled
|
Mar 6
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
| No matching records found | |||||||||
SCICLONE PHARMACEUTICALS INC No price found
CFO & Senior VP, Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.16K |
$11.18 | -$1,611,686.44 |
0
|
Oct 13
| |||
Form 4
| +816.56% | 15.29K |
$11.05 | -$162,589.70 | 17.16K |
Aug 15
| |||
Form 4
|
—
|
0
|
$10.75 | -$435,375.00 | 1.87K |
Jun 12
| |||
Form 4
|
∞
| 1.87K |
$9.60 | -$10,828.80 | 1.87K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -100.00% | -15.13K |
$7.74 | -$760,248.44 |
0
|
Scheduled
|
Oct 25 - Oct 26
| ||
Form 4
| -3.01% | -470.00 |
$7.99 | -$8,750.15 | 15.13K |
Scheduled
|
Oct 17
| ||
Form 4
| -10.71% | -1.87K |
$10.35 | -$19,370.33 | 15.6K |
Aug 29
| |||
Form 4
|
∞
| 17.48K |
$10.48 | -$241,297.97 | 17.48K |
Aug 12 - Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| -100.00% | -7.80K |
$9.51 | -$74,206.53 |
0
|
Scheduled
|
Nov 10
| ||
Form 4
|
∞
| 7.8K |
$8.05 | -$37,810.85 | 7.8K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| -100.00% | -7.80K |
$9.07 | -$70,773.21 |
0
|
Scheduled
|
Mar 12
| ||
Form 4
|
∞
| 7.8K |
$5.78 | -$27,148.66 | 7.8K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||